Management of primary T1–T4 glottic squamous cell carcinoma by transoral laser microsurgery

Andrew T. Day, Parul Sinha, Brian Nussenbaum, Dorina Kallogjeri, Bruce H. Haughey

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Objectives/Hypothesis: Evaluate the oncologic outcomes of patients with early and select advanced primary glottic squamous cell carcinoma (SCCa) managed by transoral laser microsurgery (TLM). Study Design: Retrospective cohort study. Methods: Ninety cases of TLM-managed primary glottic SCCa were identified retrospectively using a prospectively collected database. Results: Outcomes of patients with pTis–pT2a disease (n = 65) and pT2b–pT4a disease (n = 25) were, respectively: 5-year local control, 86.2% and 67.5%; 5-year disease-free survival, 64.9% and 44.9%; 5-year disease-specific survival, 96.4% and 59.0%; laryngeal preservation, 96.9% and 80%. Five of nine patients (56%) with supraglottic–glottic–subglottic tumors were local recurrence-free compared to the 70 of 81 (86%) patients with glottic, supraglottic–glottic, and glottic–subglottic tumors. Seven of 13 patients (54%) with positive or indeterminate margins were local recurrence-free compared to 68 of 77 (88%) patients with negative margins. Conclusions: Given sample size considerations, this study highlights the satisfactory oncologic outcomes of TLM-treated glottic cancer and the potential importance of margin management and disease extension within the larynx. Level of Evidence: 4 Laryngoscope, 127:597–604, 2017.

Original languageEnglish (US)
Pages (from-to)597-604
Number of pages8
Issue number3
StatePublished - Mar 1 2017


  • Larynx
  • early glottic cancer
  • head and neck
  • laryngology

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Management of primary T1–T4 glottic squamous cell carcinoma by transoral laser microsurgery'. Together they form a unique fingerprint.

Cite this